- Home
- PNNT vs TERN Comparison
PNNT vs TERN Comparison
Compare PNNT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNNT
- TERN
- Stock Information
- Founded
- PNNT 2007
- TERN 2017
- Country
- PNNT United States
- TERN United States
- Employees
- PNNT N/A
- TERN N/A
- Industry
- PNNT Finance: Consumer Services
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- PNNT Finance
- TERN Health Care
- Exchange
- PNNT Nasdaq
- TERN Nasdaq
- Market Cap
- PNNT 453.8M
- TERN 382.2M
- IPO Year
- PNNT 2007
- TERN 2021
- Fundamental
- Price
- PNNT $6.94
- TERN $4.45
- Analyst Decision
- PNNT Hold
- TERN Buy
- Analyst Count
- PNNT 2
- TERN 5
- Target Price
- PNNT $6.00
- TERN $18.30
- AVG Volume (30 Days)
- PNNT 502.2K
- TERN 1.8M
- Earning Date
- PNNT 02-10-2025
- TERN 03-13-2025
- Dividend Yield
- PNNT 13.29%
- TERN N/A
- EPS Growth
- PNNT N/A
- TERN N/A
- EPS
- PNNT 0.75
- TERN N/A
- Revenue
- PNNT $143,818,000.00
- TERN N/A
- Revenue This Year
- PNNT N/A
- TERN N/A
- Revenue Next Year
- PNNT N/A
- TERN N/A
- P/E Ratio
- PNNT $9.27
- TERN N/A
- Revenue Growth
- PNNT N/A
- TERN N/A
- 52 Week Low
- PNNT $6.43
- TERN $4.32
- 52 Week High
- PNNT $8.04
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- PNNT 45.82
- TERN 27.09
- Support Level
- PNNT $6.70
- TERN $4.38
- Resistance Level
- PNNT $7.22
- TERN $5.95
- Average True Range (ATR)
- PNNT 0.10
- TERN 0.29
- MACD
- PNNT -0.03
- TERN -0.09
- Stochastic Oscillator
- PNNT 39.83
- TERN 4.46
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.